We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

142 hedge funds and large institutions have $584M invested in Cytokinetics in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 41

16.24% more ownership

Funds ownership: 76.89% → 93.13% (+16%)

14% more capital invested

Capital invested by funds: $513M → $584M (+$70.5M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

4% less funds holding

Funds holding: 148 → 142 (-6)

13% less call options, than puts

Call options by funds: $2.59M | Put options by funds: $2.98M

Holders
142
Holders Change
-6
Holders Change %
-4.05%
% of All Funds
2.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
25
Increased
51
Reduced
41
Closed
25
Calls
$2.59M
Puts
$2.98M
Net Calls
-$389K
Net Calls Change
-$3.94M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$31.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$26.7M
3
Morgan Stanley
Morgan Stanley
New York
+$11.2M
4
Jennison Associates
Jennison Associates
New York
+$6.27M
5
Millennium Management
Millennium Management
New York
+$5.94M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$8.57M
2
OM
Opaleye Management
Massachusetts
-$7.4M
3
SI
Sofinnova Investments
California
-$2.4M
4
PVI
Pura Vida Investments
New York
-$2.14M
5
N
Nuveen
North Carolina
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Voloridge Investment Management
151
Voloridge Investment Management
Florida
– -$243K -21,355 Closed
SG Americas Securities
152
SG Americas Securities
New York
– -$167K -14,708 Closed
CM
153
Caption Management
Oklahoma
– -$164K -14,400 Closed
AG
154
Algert Global
California
– -$164K -14,388 Closed
BFM
155
Boothbay Fund Management
New York
– -$130K -11,411 Closed
PI
156
PineBridge Investments
New York
– -$119K -10,445 Closed
BC
157
Birchview Capital
Vermont
– -$114K -10,000 Closed
MAM
158
Meeder Asset Management
Ohio
– -$31K -2,652 Closed
DWA
159
Dorsey Wright & Associates
California
– -$10K -876 Closed
Group One Trading
160
Group One Trading
Illinois
– -$7.07K -688 Closed
PCG
161
Private Capital Group
Connecticut
– -$8K -674 Closed
Fifth Third Bancorp
162
Fifth Third Bancorp
Ohio
– -$5K -482 Closed
HMS
163
Hanseatic Management Services
New Mexico
– -$2K -192 Closed
PHK
164
Point72 Hong Kong
Hong Kong
– -$2K -153 Closed
GEA
165
Glen Eagle Advisors
New Jersey
– -$1.42K -125 Closed
3 4 5 6
7

CYTK Hedge Fund Activity: Q4 2019 in Review

142 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2019, worth a combined $584M — up 14% from $513M a quarter earlier.

Fund positioning in CYTK was balanced in Q4 2019: 25 funds opened new positions, 25 closed out, 51 added to existing stakes and 41 trimmed.

The largest buyer was BVF Inc, adding an estimated $31.2M. The largest seller was Federated Hermes, cutting an estimated $8.57M.

  • 142 institutional investors held Cytokinetics (CYTK) as of Q4 2019, down from 148 in Q3 2019.
  • Funds reported $584M of Cytokinetics stock for Q4 2019, up 14% quarter-over-quarter.
  • 25 funds opened new Cytokinetics positions in Q4 2019 and 25 closed out, a net change of 0 holders.
  • The largest Cytokinetics buyer in Q4 2019 was BVF Inc, an estimated $31.2M added.
  • The largest Cytokinetics seller in Q4 2019 was Federated Hermes, an estimated $8.57M sold.

Based on aggregated 13F filings for Q4 2019.